Hypoglycaemia in diabetes — formative SAQs

SAQ 1 — The severe hypoglycaemic seizure (10 marks)

A 14-year-old girl with type 1 diabetes on a hybrid closed-loop system is found having a generalised seizure at 6 am. Her father gives intramuscular glucagon and calls an ambulance. On arrival she is post-ictal with a sensor glucose of 1.7 mmol/L. (a) Outline your immediate assessment and management. (b) Classify the event by ISPAD/ADA severity. (c) Explain why her counter-regulation failed and why she did not wake. (d) Outline the prevention plan. ^{[1] [11]}

Immediate assessment and management

A seizing or post-ictal child with type 1 diabetes holds the diagnosis in her history: this is severe hypoglycaemia until proven otherwise. Secure the airway in the recovery position, give oxygen if needed, and confirm with a sensor or point-of-care glucose — which here reads 1.7 mmol/L, confirming a Level 2 biochemical event complicated by a Level 3 (severe) functional state. Her father has already given intramuscular glucagon, which is the correct community rescue drug and typically works within ten to fifteen minutes; if she had not responded, intravenous dextrose at 0.2 to 0.3 grams per kilogram would be the next step. Once she is awake and can swallow safely, follow with oral complex carbohydrate and protein, because the glucagon effect is transient and the residual insulin will continue to act. ^{[1] [11]}

Severity classification

By the ISPAD and ADA framework this is a Level 3 severe event, because the definition of severe depends on functional state rather than the glucose value: any hypoglycaemia associated with altered consciousness that requires another person to administer treatment is severe, regardless of the number. The biochemical value of 1.7 mmol/L additionally meets the Level 2 (clinically important, below 3.0) criterion. The distinction matters because a Level 3 event carries the highest recurrence risk and mandates a structured prevention review rather than a discharge on incremental adjustment. ^[1]

Why counter-regulation failed

In type 1 diabetes the three-tier defence fails in order. The first tier — falling endogenous insulin — is lost outright, because her insulin is delivered by a pump and there is no insulin secretion to switch off as glucose falls. The second tier, the glucagon response, is blunted by the loss of the intra-islet insulin signal. The third tier, the adrenaline response, is attenuated by any recent hypoglycaemia through hypoglycaemia-associated autonomic failure, which lowers the glucose threshold at which symptoms appear and can silence the autonomic warning altogether. She did not wake because impaired awareness removed the tremor and sweating that would normally have roused her, leaving the neuroglycopenic wave — seizure — as the first symptom. ^{[2] [8]}

The prevention plan

Begin with the continuous glucose monitoring download, which will reveal the asymptomatic nocturnal burden and the time below range. Run two to three weeks of strict hypoglycaemia avoidance — raising overnight targets, reducing the basal if the trace runs low, and treating every low aggressively — to restore the adrenaline warning and break the HAAF cycle. Ensure the hybrid closed-loop algorithm is tuned and that the pump is reducing basal appropriately as glucose falls, and rehearse the glucagon plan with the family and school. The DCCT trade-off means lowering HbA1c and protecting the brain must be reconciled, not traded against each other; modern registry data show they can be. ^{[4] [1]}